Publication & Citation Trends
Most Cited Works
Publications
124 total
Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial PDF
Cited by 1,043
OpenAlex
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients PDF
Cited by 392
OpenAlex
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
Cited by 1,156
OpenAlex
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer PDF
Cited by 2,115
OpenAlex
Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol) PDF
Cited by 494
OpenAlex
Research Topics
Cancer Treatment and Pharmacology
(48)
Nanoparticle-Based Drug Delivery
(19)
Cancer, Hypoxia, and Metabolism
(12)
Multiple Myeloma Research and Treatments
(9)
HER2/EGFR in Cancer Research
(9)
Frequent Co-Authors
Affiliations
Roche (Switzerland)
Brigham and Women's Hospital
Translational Genomics Research Institute
MedStar Washington Hospital Center
Roswell Park Comprehensive Cancer Center